The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.
Impaired Irs–1/Pi3–Kinase Signaling in Patients With Hcv: A Mechanism for Increased Prevalence of Type 2 Diabetes
Open accessAbstract
Patients with hepatitis C virus (HCV) infection have a greater risk of developing type 2 diabetes mellitus. However, the mechanism of this association is unclear. In this study, we examined the potential defects in upstream insulin signaling pathways in liver specimens obtained from nonobese/nondiabetic subjects with HCV infection. Fasting liver biopsy specimens were obtained from 42 HCV–infected subjects and 10 non–HCV–infected subjects matched for age and body mass index. Liver tissues were exposed to insulin and examined for the contents and phosphorylation/activation status of the upstream insulin signaling molecules by immunoprecipitation and Western blot analysis. HCV infection resulted in a trend toward a 2–fold to 3–fold increase in insulin receptor (IR) and insulin receptor substrate (IRS)–1 contents when compared with non–HCV. In contrast, insulin–stimulated IRS–1 tyrosine phosphorylation was decreased by 2–fold in HCV–infected subjects compared with non–HCV–infected subjects (P < .05). The observed reductions in IRS–1 tyrosine phosphorylation were accompanied by a 3.4–fold decrease in IRS–1/p85 phosphatidylinositol 3–kinase (PI3–kinase) association and a 2.5–fold decrease in IRS–1–associated PI3–kinase enzymatic activity (P < .05 vs. non–HCV). This was accompanied by a marked reduction in insulin–stimulated Akt phosphorylation without any alterations in mitogen–activated protein kinase (MAPK) phosphorylation. Cellular contents of the hepatic p85 subunit of PI3–kinase were comparable between HCV–infected and non–HCV–infected subjects. In conclusion, we found that (1) HCV infection leads to a postreceptor defect in IRS–1 association with the IR and (2) insulin signaling defects in hepatic IRS–1 tyrosine phosphorylation and PI3–kinase association/activation may contribute to insulin resistance, which leads to the development of type 2 diabetes mellitus in patients with HCV infection.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Measurement of protein using bicinchoninic acid
Smith, P. K., Krohn, R. I., Hermanson, G. T., Mallia, A. K., Gartner, F. H., Provenzano, M. D., Fujimoto, E. K., Goeke, N. M., Olson, B. J., & Klenk, D. C. (1985) · Analytical Biochemistry · doi:10.1016/0003-2697(85)90442-7 · Cited by 18,482
The phosphoinositide 3-kinase pathway
Cantley, L. C. (2002) · Science · doi:10.1126/science.296.5573.1655 · Cited by 5,621
Structure of the insulin receptor substrate IRS-1 defines a unique signal transduction protein
Sun, X. J., Rothenberg, P., Kahn, C. R., Backer, J. M., Araki, E., Wilden, P. A., Cahill, D. A., Goldstein, B. J., & White, M. F. (1991) · Nature · doi:10.1038/352073a0 · Cited by 1,574
Aguirre, V., Werner, E. D., Giraud, J., Lee, Y. H., Shoelson, S. E., & White, M. F. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m101521200 · Cited by 1,010
Qiao, L.-Y., Zhande, R., Jetton, T. L., Zhou, G., & Sun, X. J. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m201494200 · Cited by 104
Cited by
Insulin resistance: a metabolic pathway to chronic liver disease
Bugianesi, E., McCullough, A. J., & Marchesini, G. (2005) · Hepatology · doi:10.1002/hep.20920 · Cited by 900
Romero-Gómez, M., Del Mar Viloria, M., Andrade, R. J., Salmerón, J., Diago, M., Fernández-Rodríguez, C. M., Corpas, R., Cruz, M., Grande, L., Vázquez, L., et al. (2005) · Gastroenterology · doi:10.1053/j.gastro.2004.12.049 · Cited by 732
Insulin resistance is a cause of steatosis and fibrosis progression in chronic hepatitis C
Fartoux, L., Poujol-Robert, A., Guéchot, J., Wendum, D., Poupon, R., & Serfaty, L. (2005) · Gut · doi:10.1136/gut.2004.050302 · Cited by 375
Fabrizi, F., Martin, P., Dixit, V., Bunnapradist, S., Kanwal, F., & Dulai, G. (2005) · American Journal of Transplantation · doi:10.1111/j.1600-6143.2005.01040.x · Cited by 208
Wang, C.-S., Wang, S.-T., Yao, W.-J., Chang, T.-T., & Chou, P. (2007) · American Journal of Epidemiology · doi:10.1093/aje/kwm061 · Cited by 166
Metadata
- Authors
- Aytug, S., Reich, D., Sapiro, L. E., Bernstein, D., & Begum, N.
- Venue
- Hepatology
- Published
- 2003-12
- Volume
- 38
- Issue
- 6
- Pages
- 1384-1392
- ISSN
- 0270-9139 (ISSN-L)
- OpenAlex
- W2081454569
- Cited by
- 340
- References
- 5
- FWCI
- 11.42
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Impaired Irs–1/Pi3–Kinase Signaling in Patients With Hcv: A Mechanism for Increased Prevalence of Type 2 Diabetes. https://app.cochat.ai/papers/10.1016/j.hep.2003.09.012
- The paper
- Aytug, S., Reich, D., Sapiro, L. E., Bernstein, D., & Begum, N. (2003). Impaired Irs–1/Pi3–Kinase Signaling in Patients With Hcv: A Mechanism for Increased Prevalence of Type 2 Diabetes. Hepatology. https://doi.org/10.1016/j.hep.2003.09.012
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.